NCT07631247 · NOT YET RECRUITING

iPath for CP Pilot

This small pilot tests a phone and tablet app that screens care partners of people with dementia for depression and guides them toward evidence-based online treatment. Researchers are measuring whether the app is workable and acceptable over two weeks. It is an early feasibility study, not a test of whether it works. Phase is not applicable.

Eligibility criteria

Inclusion Criteria:
* For 2 Week iPath*CP Pilot:
  1. Adults (≥18 years)
  2. Care partners of persons with dementia who score ≥5 on the PHQ-8 AND PHQ-9 screen
  3. Can communicate in English
  4. Have access to an Android based or Apple iOS based phone or tablet capable of running the iPath application.
For Debrief Interviews:
* Care partners: Interviews will be conducted with a purposeful sample of 6 patients already consented into the study at the completion of T1 data collection, ensuring representation by sex (male/female), perceived usability (low/high) of iPath*CP and race/ethnicity.
* Clinicians: Interviews will be conducted with clinicians and clinical staff who had patients involved in the project.
Exclusion Criteria:
* Care partners with:
  1. PHQ-8 score \<5
  2. Answering positively for question 9 of the PHQ-9 who also screen positive for suicidal ideation with method, intent, plan or a recent prior suicide/self-harm attempt, as determined by a positive endorsement of items 3, 4, 5 or 6b ("Past 3 Months") on the Columbia-Suicide Severity Rating Scale (C-SSRS) and determined by Dr. Mistler, Psychiatrist at DH, not to be eligible.
  3. With bipolar disorder or psychosis (documented in the electronic medical record [EMR])
  4. With significant cognitive impairment (documented in the EMR or self-reported during eligibility screening)
  5. With no access to an Android or Apple device
For Debrief Interviews:
* Patients: Participants withdrawn from the 2 Week iPath*CP Pilot.
* Clinicians: None.

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2026-10-02

View full record on ClinicalTrials.gov

All APOE4 clinical trials